 |
 |
|
|
|
| Imatinib mesylate |
 |
| Imatinib mesylate |
 |
Imatinib mesylate
CAS: 220127-57-1
MF: C30H35N7O4S
MW: 589.71
Description: White crystalline powder.
Usage: A tyrosine kinase inhibitor, Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL).
Storage: Preserve in well closed container.
Standard: Enterprise standard
Assay: not less than 98.5%
|
 |
Imatinib mesylate
CAS: 220127-57-1
MF: C30H35N7O4S
MW: 589.71
Description: White crystalline powder.
Usage: A tyrosine kinase inhibitor, Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL).
Storage: Preserve in well closed container.
Standard: Enterprise standard
Assay: not less than 98.5%
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
